Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Entorhinal cortex epigenome-wide association study highlights four novel loci showing differential methylation in Alzheimer’s disease

Sommerer Y. et al, (2023), Alzheimer's Research & Therapy, 15

Brain-derived and in vitro-seeded alpha-synuclein fibrils exhibit distinct biophysical profiles

Lee SS. et al, (2023)

Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disorders.

Altay MF. et al, (2022), Acta Neuropathol Commun, 10

Common signatures of differential microRNA expression in Parkinson’s and Alzheimer’s disease brains

Dobricic V. et al, (2022), Brain Communications, 4

Differential microRNA expression analyses across two brain regions in Alzheimer's disease.

Dobricic V. et al, (2022), Transl Psychiatry, 12

Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disorders

Altay MF. et al, (2022)

Prion-like α-synuclein pathology in the brain of infants with Krabbe disease

Hatton C. et al, (2022), Brain, 145, 1257 - 1263

Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies

Poggiolini I. et al, (2022), Brain, 145, 584 - 595

Neuropathological evidence of body-first vs. brain-first Lewy body disease

Borghammer P. et al, (2022), Neurobiology of Disease

Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture.

Chia R. et al, (2021), Nat Genet, 53, 294 - 303

Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study

Attems J. et al, (2021), Acta Neuropathologica, 141, 159 - 172

Human‐Specific Transcriptome of Ventral and Dorsal Midbrain Dopamine Neurons

Monzón‐Sandoval J. et al, (2020), Annals of Neurology, 87, 853 - 868

Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies.

Orme T. et al, (2020), Acta Neuropathol Commun, 8

Heritability and genetic variance of dementia with Lewy bodies.

Guerreiro R. et al, (2019), Neurobiol Dis, 127, 492 - 501

A comprehensive screening of copy number variability in dementia with Lewy bodies

Kun-Rodrigues C. et al, (2019), Neurobiology of Aging, 75, 223.e1 - 223.e10

Alzheimer's disease pathology explains association between dementia with Lewy bodies and APOE‐ε4/TOMM40 long poly‐T repeat allele variants

Prokopenko I. et al, (2019), Alzheimer's & Dementia: Translational Research & Clinical Interventions, 5, 814 - 824

Detection of alpha-synuclein conformational variants from gastro-intestinal biopsy tissue as a potential biomarker for Parkinson's disease

Ruffmann C. et al, (2018), Neuropathology and Applied Neurobiology, 44, 722 - 736

LRP10 in α-synucleinopathies

Guerreiro R. et al, (2018), The Lancet Neurology, 17, 1032 - 1033

Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study

Guerreiro R. et al, (2018), The Lancet Neurology, 17, 64 - 74

DNAJC12 and dopa-responsive nonprogressive parkinsonism

Straniero L. et al, (2017), Annals of Neurology, 82, 640 - 646

Load More

Include forthcoming?